Scientists at The Wistar Institute have identified a previously overlooked mediator in the body's response to life-threatening infections: hippuric acid, a metabolite produced when gut bacteria break ...
A new study published in Pharmaceuticals and conducted by researchers from McGill University sheds light on how cannabidiol ...
CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...
New review reveals how non-genomic estrogen signaling undermines treatment response and fuels tumor progression Hormone receptor–positive breast ...
Hepatocellular carcinoma (HCC), characterized by high aggressiveness and recurrence, poses a significant global health challenge. The interplay between the tumour microenvironment and exogenous ...
A new scientific review published in the journal Pathophysiology examines how cannabinoids—both those produced naturally in ...
Abnormal clumps of proteins like α-synuclein, amyloid beta and tau are associated with neurodegenerative conditions like ...
InvestorsHub on MSN
Hoth Therapeutics gains after winning China patent for HT-KIT cancer program
Shares of Hoth Therapeutics Inc (NASDAQ:HOTH) advanced 3.6% in premarket trading on Wednesday after the clinical-stage ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced that the China National Intellectual Property ...
The China National Intellectual Property Administration approved the patent covering Hoth’s HT-KIT technology, which is ...
The field of cancer biology has witnessed rapid advances in our understanding of microRNAs (miRNAs) as crucial regulators of ...
Cirrhotic cardiomyopathy (CCM) is a significant complication of cirrhosis, but its progression and underlying mechanisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results